Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial
======================================================================================================================================================================

* Wenwen Zhang
* Shuang Tong
* Bingyang Hu
* Tao Wan
* Haowen Tang
* Feilong Zhao
* Tianyu Jiao
* Junfeng Li
* Ze Zhang
* Jinping Cai
* Huiyi Ye
* Zhanbo Wang
* Shiqing Chen
* Yafei Wang
* Xuerui Li
* Fangzhou Wang
* Junning Cao
* Lantian Tian
* Xiaochen Zhao
* Mingyi Chen
* Hongguang Wang
* Shouwang Cai
* Minggen Hu
* Yuezong Bai
* Shichun Lu